Results 1 to 10 of about 13,068 (179)
Annals of Hepatology, 2003 Hepatorenal syndrome is complication of advanced cirrhosis characterized by renal failure, changes in systemic blood pressure, and increased activity of endogenous vasoactive systems.
Andrés Cárdenas, M.D. +1 more
doaj +7 more sources
Korean J Gastroenterol, 2023 Hepatorenal syndrome (HRS) is a critical and potentially life-threatening complication of advanced liver disease, including cirrhosis. It is characterized by the development of renal dysfunction in the absence of underlying structural kidney pathology.
Choi JC, Yoo JJ.
europepmc +3 more sources
Türk Yoğun Bakim Derneği Dergisi, 2012 Renal failure is a common major complication in patients with advanced cirrhosis and generally indicates a poor prognosis when combined with liver failure.
Pınar Zeyneloğlu
doaj +3 more sources
Hepatorenal Syndrome: direct treatment costs and characteristics of patients admitted to intensive care [PDF]
Einstein (São Paulo)Objective The purpose of this study was to describe the direct medical costs incurred in Brazil for the treatment of Hepatorenal Syndrome in intensive care and intermediate therapy care units, and to investigate the impact of this syndrome on patient ...
Franciele Robes Hortelã +5 more
doaj +2 more sources
Hepatorenal syndrome: an update [PDF]
São Paulo Medical Journal, 2007 Hepatorenal syndrome (HRS) is the development of renal failure in patients with chronic previous liver disease, without clinical or laboratory evidence of previous kidney disease.
Tércio Genzini +1 more
doaj +4 more sources
Role of renal Duplex ultrasonography in evaluation of hepatorenal syndrome
Egyptian Liver Journal, 2021 Background Hepatorenal syndrome is a potentially fatal complication of advanced liver disease. Markers for early diagnosis and identification of high-risk patients are lacking.
Mohamad Sherif Mogawer +6 more
doaj +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Hepatology, EarlyView., 2022 Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran +17 more
wiley +1 more source
BMC Gastroenterology, 2023 Background and aim In China, hepatorenal syndrome is a serious complication in the decompensated stage of hepatitis B cirrhosis, which requires early clinical intervention, so the early diagnosis of hepatorenal syndrome is crucial. This study establishes
Shouhao Wang +8 more
doaj +1 more source